Infectious Diseases Society of America (IDSA) recommends that either the clinical judgment criteria or the MASCC<unk>  tool can be used to stratify risk for patients presenting with fever and neutropenia.<unk><unk>  should then inform decisions about the type of regimen and appropriate venue for delivery of empirical antibiotics, as well as the timing of hospital discharge.  High-risk patients should<unk> ly receive IV empirical antibiotic therapy in the hospital, whereas low-risk patients may be candidates for oral and/or outpatient empirical antibiotic therapy.
Febrile neutropenia initial assessment
Febrile neutropenia diagnostic criteria
Febrile neutropenia laboratory findings
Febrile neutropenia physical examination
Febrile neutropenia other diagnostic studies
Febrile neutropenia risk factors
T-cell prolymphocytic leukemia physical examination
Splenic marginal zone lymphoma physical examination